Work

Exposure-oriented molecular profiling and machine learning prioritize the citrus flavonoid nobiletin as an antitumor candidate for colorectal cancer: integrated pharmacological evaluation

Year: 2026
Type: article
Abstract: Colorectal cancer (CRC) remains a major health burden, and the pharmacologically relevant constituents of complex natural-product preparations are difficult to prioritize because chemical presence does not necessarily reflect systemic exposure. Here, we established an exposure-oriented pharmacological workflow integrating ultra-performance liquid chromatography–quadrupole time-of-flight tandem mass spectrometry (UPLC-QTOF-MS/MS) serum profiling, machine learning, public human CRC single-cell RNA sequencing, target integration, molecular modeling, and experimental evaluation to identify and characterize a prioritized bioactive candidate from Wumen Xianzhu Jiedu Decoction (WMXZJDD). Serum profiling after oral administration annotated 127 serum-exposure-related features, including 42 prototype components and 85 putative metabolites. After parent-compound mapping, deduplication, and structural filtering, 47 exposure-related parent compounds were retained for machine-learning prioritization. Nobiletin (NOB), a citrus-derived polymethoxylated flavonoid, ranked first according to the four-model composite prioritization score (0.77). Integrative analyses supported MAPK/JNK signaling as a candidate mechanism underlying NOB activity. NOB inhibited CT26 cell proliferation (24-h IC 50 , 70.8 μM) and reduced EdU incorporation, accompanied by increased JNK phosphorylation and upregulation of Beclin-1, ATG5, and NCOA4. In syngeneic CT26 tumor-bearing mice, NOB suppressed tumor growth without treatment-associated body-weight loss. These findings prioritize NOB as an anti-CRC candidate within an exposure-informed screening framework and illustrate the potential of integrating serum profiling, machine learning, and pharmacological evaluation for active-component discovery from complex natural-product preparations.
Language: English
Subfield: Pharmacology
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7225909949
FWCI:
Cites: 61
Cited by:
Related to: 10
Parts: 2